Having determined that NKX2-5 is a critical factor in VSMC phenotypic modulation and that hypoxia is one of the main regulatory pathways, we sought to confirm this in vivo using a hypoxia-induced mouse model of PAH. This evidence concerns the gene NKX2-5 and pulmonary arterial hypertension.